Cargando…

Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink

The Vaccine Safety Datalink (VSD) conducts active surveillance and vaccine safety research studies. Since the start of the U.S. COVID-19 vaccination program, the VSD has conducted near real-time safety surveillance of COVID-19 vaccines using Rapid Cycle Analysis. VSD investigators developed an inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Kenigsberg, Tat'Yana A., Hause, Anne M., McNeil, Michael M., Nelson, Jennifer C., Ann Shoup, Jo, Goddard, Kristin, Lou, Yingbo, Hanson, Kayla E., Glenn, Sungching C., Weintraub, Eric S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989890/
https://www.ncbi.nlm.nih.gov/pubmed/35428497
http://dx.doi.org/10.1016/j.vaccine.2022.04.010
_version_ 1784683269518786560
author Kenigsberg, Tat'Yana A.
Hause, Anne M.
McNeil, Michael M.
Nelson, Jennifer C.
Ann Shoup, Jo
Goddard, Kristin
Lou, Yingbo
Hanson, Kayla E.
Glenn, Sungching C.
Weintraub, Eric S.
author_facet Kenigsberg, Tat'Yana A.
Hause, Anne M.
McNeil, Michael M.
Nelson, Jennifer C.
Ann Shoup, Jo
Goddard, Kristin
Lou, Yingbo
Hanson, Kayla E.
Glenn, Sungching C.
Weintraub, Eric S.
author_sort Kenigsberg, Tat'Yana A.
collection PubMed
description The Vaccine Safety Datalink (VSD) conducts active surveillance and vaccine safety research studies. Since the start of the U.S. COVID-19 vaccination program, the VSD has conducted near real-time safety surveillance of COVID-19 vaccines using Rapid Cycle Analysis. VSD investigators developed an internal dashboard to facilitate visualization and rapid reviews of large weekly automated vaccine safety surveillance data. Dashboard development and maintenance was informed by vaccine surveillance data users and vaccine safety partners. Key metrics include population demographics, vaccine uptake, pre-specified safety outcomes, sequential analyses results, and descriptive data on potential vaccine safety signals. Dashboard visualizations are used to provide situational awareness on dynamic vaccination coverage and the status of multiple safety analyses conducted among the VSD population. This report describes the development and implementation of the internal VSD COVID-19 Vaccine Dashboard, including metrics used to develop the dashboard, which may have application across various other public health settings.
format Online
Article
Text
id pubmed-8989890
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-89898902022-04-11 Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink Kenigsberg, Tat'Yana A. Hause, Anne M. McNeil, Michael M. Nelson, Jennifer C. Ann Shoup, Jo Goddard, Kristin Lou, Yingbo Hanson, Kayla E. Glenn, Sungching C. Weintraub, Eric S. Vaccine Article The Vaccine Safety Datalink (VSD) conducts active surveillance and vaccine safety research studies. Since the start of the U.S. COVID-19 vaccination program, the VSD has conducted near real-time safety surveillance of COVID-19 vaccines using Rapid Cycle Analysis. VSD investigators developed an internal dashboard to facilitate visualization and rapid reviews of large weekly automated vaccine safety surveillance data. Dashboard development and maintenance was informed by vaccine surveillance data users and vaccine safety partners. Key metrics include population demographics, vaccine uptake, pre-specified safety outcomes, sequential analyses results, and descriptive data on potential vaccine safety signals. Dashboard visualizations are used to provide situational awareness on dynamic vaccination coverage and the status of multiple safety analyses conducted among the VSD population. This report describes the development and implementation of the internal VSD COVID-19 Vaccine Dashboard, including metrics used to develop the dashboard, which may have application across various other public health settings. Elsevier Science 2022-05-11 2022-04-08 /pmc/articles/PMC8989890/ /pubmed/35428497 http://dx.doi.org/10.1016/j.vaccine.2022.04.010 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Kenigsberg, Tat'Yana A.
Hause, Anne M.
McNeil, Michael M.
Nelson, Jennifer C.
Ann Shoup, Jo
Goddard, Kristin
Lou, Yingbo
Hanson, Kayla E.
Glenn, Sungching C.
Weintraub, Eric S.
Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
title Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
title_full Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
title_fullStr Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
title_full_unstemmed Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
title_short Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
title_sort dashboard development for near real-time visualization of covid-19 vaccine safety surveillance data in the vaccine safety datalink
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989890/
https://www.ncbi.nlm.nih.gov/pubmed/35428497
http://dx.doi.org/10.1016/j.vaccine.2022.04.010
work_keys_str_mv AT kenigsbergtatyanaa dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink
AT hauseannem dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink
AT mcneilmichaelm dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink
AT nelsonjenniferc dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink
AT annshoupjo dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink
AT goddardkristin dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink
AT louyingbo dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink
AT hansonkaylae dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink
AT glennsungchingc dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink
AT weintrauberics dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink